Tumour necrosis factor-a (TNF) is a cytokine endowed with multiple functions, depending on the cellular and environmental context. TNF receptor engagement induces the formation of a multimolecular complex including the TNFR-associated factor TRAF2, the receptor-interaction protein kinase RIP1 and the cellular inhibitor of apoptosis cIAP1, the latter being essential for NF-kB activation. Here, we show that cIAP1 also regulates TNF-induced actin cytoskeleton reorganization through a cdc42-dependent, NF-kB-independent pathway. Deletion of cIAP1 prevents TNF-induced filopodia and cdc42 activation. The expression of cIAP1 or its E3-ubiquitin ligase-defective mutant restores the ability of cIAP1 À / À MEFs to produce filopodia, whereas a cIAP1 mutant unable to bind TRAF2 does not. Accordingly, the silencing of TRAF2 inhibits TNF-mediated filopodia formation, whereas silencing of RIP1 does not. cIAP1 directly binds cdc42 and promotes its RhoGDIa-mediated stabilization. TNF decreases cIAP1-cdc42 interaction, suggesting that TNF-induced recruitment of cIAP1/TRAF2 to the receptor releases cdc42, which in turn triggers actin remodeling. cIAP1 also regulates cdc42 activation in response to EGF and HRas-V12 expression. A downregulation of cIAP1 altered the cell polarization, the cell adhesion to endothelial cells and cell intercalation, which are cdc42-dependent processes. Finally, we demonstrated that the deletion of cIAP1 regulated the HRas-V12-mediated transformation process, including anchoragedependent cell growth, tumour growth in a xenograft model and the development of experimental metastasis in the lung.
INTRODUCTION
Tumour necrosis factor-a (TNF) is a mediator of immune and inflammatory response produced by activated monocytes and macrophages. This cytokine promotes cell proliferation, cell differentiation, cytokine secretion and cell death, depending on the cellular and environmental context. 1 TNF also affects cell shape and cell movement, which may contribute to the recruitment of fibroblasts or neutrophils to the site of tissue injury. 2 Such morphogenetic modifications involve a dynamic rearrangement of the actin cytoskeleton controlled by small GTPases of the Rho family, which includes rhoA, rac1 and cdc42. For example, in endothelial cells, TNF induces the sequential activation of rac1, rhoA and cdc42, which leads to the formation of stress fibers and to cell contraction. 2, 3 In fibroblasts and macrophages, TNF triggers the activation of cdc42, which is responsible for the transient formation of the actin-rich protrusions known as filopodia. 2, 4, 5 Rho GTPases act as molecular switches that transduce the signal from membrane receptors to downstream effectors by shuttling between a GTPbound active state and a GDP-bound inactive state. Once activated, they are either rapidly recycled into the inactive form or degraded by the ubiquitin-proteasome machinery. The Rho GTPase activation cycle is controlled by guanine-nucleotide exchange factors (GEFs), which catalyse the transfer of GDP-bound forms into GTP-bound forms, by GTPase-activation proteins (GAPs), which inactivate Rho GTPases by hydrolysing the GTP, and by guanine-nucleotide dissociation inhibitors (GDIs), which are chaperones that stabilize Rho GTPases in a cytosolic inactive state. 2, 6, 7 TNF binds two related membrane surface receptors. TNFR1, whose expression is ubiquitous, mediates most of the biological effects of the cytokine, whereas TNFR2 expression is restricted mostly to lymphocytes and endothelial cells. Upon ligand stimulation, TNFR1 recruits, in a membrane-associated complex, the cytosolic adaptor TNFR1-associated death domain protein (TRADD), the TNFR-associated factors (TRAFs), the receptorinteraction protein kinase 1 (RIPK1) and the cellular inhibitors of apoptosis (cIAPs). [8] [9] [10] [11] This molecular platform activates ubiquitindependent signaling pathways, resulting in the nuclear factorkappaB (NF-kB), mitogen-activated protein kinase (MAPK) activations and the expression of genes encoding for cytokines, adhesion molecules, survival and differentiation factors. [11] [12] [13] In the absence of cIAPs or when the NF-kB signaling is blocked, secondary cytoplasmic complexes leading to cell death are generated from the first one. [14] [15] [16] [17] cIAPs, including cIAP1 and cIAP2, are E3-ubiquitin ligases formed as a result of the presence of a C-terminal RING domain. In addition to the RING, they own three baculovirus IAP repeat (BIR) domains mediating protein-protein interactions, a ubiquitinbinding-associated (UBA) domain that allows the recruitment of cIAPs into protein complexes 18 and a caspase recruitment domain (CARD) that regulates the E3 activity of the RING domain. 19 Numerous ubiquitination targets and/or partners of cIAP1 have been identified, including signaling molecules, regulators of NF-kB activating pathways 20 and transcriptional regulators such as Mad1 21 and E2F1. 22 In the TNFR1 signaling pathway, cIAP1 promotes its own ubiquitination and the ubiquitination of the kinase RIP1 required for the activation and survival of NF-kB , whereas it inhibits the formation of the RIP1-containing secondary intracellular platforms that trigger cell death. 9, 11, 12, [14] [15] [16] cIAP1 is also a potent inhibitor of the alternative NF-kB activating pathway through ubiquitination leading to degradation of NIK. 23, 24 The present study demonstrates that cIAP1 also regulates filopodia formation in response to TNF, EGF and oncogenic HRas-V12 expression. cIAP1 directly interacts with cdc42 and regulates its activity by promoting its RhoGDI-mediated stabilization. We show that TNF stimulation disrupts the cIAP1/cdc42 interaction and facilitates cdc42-mediated actin rearrangement, independently of NF-kB activation. A downregulation of cIAP1 affected cdc42-regulated processes including cell polarization, cell adhesion, cell intercalation and HRas-V12-mediated cell transformation.
RESULTS
Deletion of cIAP1 alters actin cytoskeleton organization. A previous work from Oberoi et al. 25 demonstrated that murine embryonic fibrobasts (MEFs) from birc2-deficient mice (cIAP1 À / À ) displayed an altered morphology when compared with their wildtype counterparts. Accordingly, serum-starved cIAP1 À / À MEFs Figure 1 . exhibited elongated and contracted cell bodies and the presence of subtle fine extended protrusions similar to filopodia (Figure 1a ), an effect quantified by counting cells harbouring more than five filopodia-like structures (Figure 1b) . Filopodia is specifically controlled by RhoGTPase cdc42. 6 The expression of cIAP1 or a dominant-negative form of cdc42 (cdc42-N17) abolished the filopodia-like structures in cIAP1 À / À MEFs (Figures 1b and c) , demonstrating a cdc42-dependent phenomenon. The adaptor TRAF2 is a well-known partner of cIAP1 that is required for cIAP1 recruitment into the TNFR complex. The expression of the cIAP1 L47A mutant, which cannot interact with TRAF2 22 (Supplementary Figure 1 ), or the E3-ubiquitin ligase activity-defective mutant (cIAP1 H588A ), also impeded filopodia-like formation (Figures 1b and c) . Depletion of cIAP1 leads to a stabilization of the NF-kB-inducing kinase NIK and a constitutive activation of NF-kB. 17, 26 Neither the silencing of NIK nor the expression of IkBsuper repressor (IkB-SR) abolished spontaneous filopodia in cIAP1 À / À MEFs significantly (Figures 1b and c) . The expression of IkB-super repressor (IkB-SR) did not alter the capacity of cIAP1 to suppress filopodia either (Figures 1b and c) , demonstrating that the reorganization of actin cytoskeleton in cIAP1 À / À MEFs was independent of NF-kB activation. cIAP1 mediates cdc42 stabilization through RhoGDIa A western blot analysis of Rho GTPases demonstrated a reduced expression of cdc42 in cIAP1-depleted cells (Figures 2a and b) . However, the GTP-bound/total cdc42 ratio was increased (Figures 2b and c) , demonstrating a constitutive activation of cdc42, which was associated with an increase in the phosphorylation of the direct cdc42 effector PAK1 (Figure 2c ). Once activated, RhoGTPAses can be degraded by the proteasome system. The proteasome inhibitor MG132 prevented the downregulation of cdc42 (Figures 2a and b) . Conversely, overexpression of cIAP1 in NIH3T3 or restoration of cIAP1 in cIAP1 À / À MEF increased the total level of cdc42 (Figures 2d and e, Supplementary Figure 2) , mostly in the cytosol-enriched fraction (Figure 2f) , and, to a lesser extent, the GTP-bound cdc42 (Figure 2d ). On the whole, our data suggest that cIAP1 could stabilize cdc42, mainly in its cytosolic inactive state. RhoGDIa is an important regulator of Rho GTPases that directly binds the proteins and stabilizes the cytosolic inactive forms. 7, 27 Silencing of RhoGDIa prevented the cIAP1-mediated upregulation of cdc42 (Figure 2e, Supplementary Figure 2) , and overexpression of cIAP1 increased the proportion of RhoGDIa associated with cdc42; that is, co-precipitation experiments showed that an equivalent quantity of RhoGDIa pulled down more cdc42 in cIAP1-overexpressing cells (Figure 2g ), demonstrating the importance of RhoGDIa in cIAP1-mediated cdc42 stabilization. cIAP1 interacts with cdc42. We demonstrated an interaction of cIAP1 with cdc42, RhoA and Rac1 in a glutathione S-transferase (GST) pull-down assay (Figure 3a) . Similar results were obtained in a co-immunoprecipation experiment using Myc-cIAP1 and EGFP-Rho GTPases (Supplementary Figure 3A) . Cdc42 bound to cIAP1 BIR-containing constructs (BIR1-3, BIR 1-2 and BIR 2-3) and to the single BIR2 domain with high affinity, whereas TRAF2 bound to BIR1 (Figure 3b ). Both GTP-and GDP-loaded cdc42 bound cIAP1, whereas only the GTP form bound the cdc42 effector PAK1 (Figure 3c , Supplementary Figure 3B ). These results were confirmed using the Surface Plasmon Resonance technology (Biacore system) showing that the BIR domains of cIAP1 directly bound GDP-and GTP-loaded recombinant cdc42 with an affinity quite similar (Figure 3d ). An interaction of cdc42 with cIAP1, RhoGDIa and TRAF2 was observed in vivo in co-immunoprecipitation experiments (Figure 3e ). The use of recombinant proteins demonstrated that cIAP1, but not TRAF2, could directly interact with cdc42. However, TRAF2 bound GST-cdc42 in the presence of cIAP1 (Figure 3f À / À MEFs to form filopodia in response to TNF was restored by the expression of wild-type cIAP1 as well as the E3-defective mutant cIAP1 H588A (Figures 5d and e) . In contrast, the cIAP1 L47A mutant did not restore TNF-induced filopodia formation in cIAP1 À / À MEFs (Figures 5d and e) , suggesting a role of TRAF2 in this process. Accordingly, silencing of TRAF2 in wt MEFs inhibited TNFmediated filopodia formation (Figure 5f ), whereas silencing of RIP1, which is the cIAP1-ubiquitin target in the TNF signaling pathway, did not (Figure 5f ). The TNF-mediated filopodia formation in cIAP1-reconstituted cIAP1 À / À MEFs was totally inhibited by the expression of the dominant-negative form of cdc42 (cdc42-N17), but was not affected by the expression of IkB-SR (Figure 5e ). Overall, TNF induced filopodia formation via a cdc42-, cIAP1-and TRAF2-dependent but RIP1-and NF-kB-independent signaling pathway. Moreover, the cIAP1 E3-ubiquitin ligase required for TNF-induced ubiquitination of RIP1 and activation of NF-kB was dispensable. Of note, the expression of the cIAP1 L47A mutant in wt MEFs inhibited TNF-induced filopodia formation (Figure 5e ), Figure 4 . Silencing of cIAP1 inhibits TNF-mediated Filopodia formation. NIH3T3 fibroblasts were transfected with control (si-Co) or cIAP1 (si-cIAP1)-targeting siRNAs, serum starved for 16 h and stimulated for an indicated time with 100 ng/ml TNF. (a, b) Immunoflorescence analysis of F-actin staining was conducted using AlexaFluor488-conjugated Phalloidin. Filopodia were quantified by counting cells harbouring more than five filopodia (b). More than 100 cells were analysed. The mean reflects ± s.d. of at least three independent experiments. Statistical analysis was performed using the Student t-test. ***P ¼ 0.004; *P ¼ 0.028. (c) Western blot analysis of cdc42 and Rac1, total and phosphorylated forms of cofilin and GSK3a and b. Activated GTP-bound cdc42 and Rac1 were pulled down using the GST-PAK1-CRIB domain before immunoblot analysis. One representative experiment is shown. HSC70 was used as the loading control. Figure 6) . We then analysed the activation of cdc42, Rac1 and RhoA in response to TNF stimulation in MEFs (Figure 6a ). As expected, TNF did not stimulate cdc42 in cIAP1 À / À MEFs. The activation of Rac1, which occurs downstream of cdc42 in the TNF-signaling pathway, 4 was also abolished. The expression of the cIAP1 L47A mutant also decreased TNF-induced cdc42 activation and PAK1 phosphorylation, confirming the dominant-negative effect of this mutant (Figure 6b ). Altogether, our results suggest that cIAP1 is required for cdc42 activation in response to TNF. Co-immunoprecipitation experiments showed that TNF exposure decreased the interaction of cIAP1 and TRAF2 with cdc42 ( Figure 6c ). Unlike TNF, which induces cdc42-dependent Rac1 activation, 4 EGF activates cdc42 and Rac1 in an independent manner. Deletion Figure 5 . TNF-mediated filopodia formation is impaired in MEF cIAP1 À / À MEFs were transfected with encoding plasmid vector (d, e) or si-RNAs (f ), serum starved and treated for 10 min with 100 ng/ml TNF. The expression of the constructs and the silencing efficiency were checked by immunoblotting analysis (d, f: lower panel). Filopodia were detected as in A and counted (e, f ). More than 100 cells were analysed. Results were expressed as fold filopodia induction/untreated cells (UT). The mean±s.d. reflects at least three independent experiments (d, e). Statistical analysis was performed using the Student t-test. ***Po0.001; **Po0.01; *Po0.05. (Figure 6a) . Moreover, deletion of cIAP1 did not alter seruminduced RhoA activation (Figure 6a) , suggesting a specific regulation of cdc42 activation by cIAP1. The EGF-induced filopodia formation was abolished in cIAP1 À / À MEF and was restored by the expression of cIAP1 (Supplementary Figure 7) . Silencing of TRAF2 did not inhibit EGF-induced filopodia formation (Supplementary Figure 7) , suggesting a general regulation of cdc42 by cIAP1, whereas TRAF2 specifically regulated the TNF signaling pathway. cIAP1 regulates cdc42 functions Next, we examined the importance of cIAP1 in the cellular functions of cdc42. cdc42 is a specific regulator of cell polarization. 31, 32 A downregulation of cIAP1 significantly affected cell polarization, as evaluated by analysing the Golgi apparatus reorientation to face the leading edge, 5 hours after fibroblast scratching (Figure 7a ). cdc42 is also an important intermediate in the Ras-mediated cell anchorage-independent cell growth and transformation pathways. [33] [34] [35] [36] The expression of oncogenic HRas-V12 induced the activation of cdc42, which was completely blocked in cIAP1 À / À MEFs (Figure 7b ). Deletion of cIAP1 significantly decreased HRas-V12-mediated cell growth in soft agar medium (Figure 7c ), inhibited the growth of tumour cells when subcutaneously injected into nude mice (Figure 7d ) and delayed the apparition of lung cancer foci after injection of cells into the tail vein (Figure 7e, Supplementary Figure 8) .
Several steps of the metastatic process are controlled by RhoGTPases, including the dissemination of tumour cells through the lymph or the blood, their adhesion to vessel endothelium and their subsequent migration through the endothelium to colonize adjacent organs. A recent report from Reymond et al. demonstrated that the attachment of cancer cells to the endothelial monolayer and their transendothelial migration is more specifically controlled by cdc42. 37 As demonstrated for cdc42, 37 silencing of cIAP1 significantly reduced the adhesion of PC3 cells to the HUVEC monolayer and their intercalation between endothelial cells (Figure 7f ). We then analysed the capacity of MEFs, untransformed or transformed by HRas-V12, to adhere to and Figure 6 . Deletion of cIAP1 prevents cdc42 activation. (a) Immunoblotting analysis of cdc42, Rac1 and RhoA in MEFs from wt or cIAP1-deleted mice. Cells were serum starved for 16 h, and then stimulated for 10 min with 100 ng/ml TNF or EGF or 10% FBS as indicated. Activated GTP-bound cdc42 and Rac1 were pulled down with the GST-PAK1-CRIB domain and GTP-RhoA with a GST-Rhotekin-Rho binding domain before immunoblot analysis. One representative experiment is shown. The ratio GTP-bound/total GTPases is evaluated by a densitometric analysis of the shown immunoblot. Because of the differential basal level of expression of cdc42 as observed in Figure 3 , cell lysates from wt and cIAP1 À / À MEFs were deposited onto a separate gel and revealed separately. (b) Immunoblotting analysis of cdc42 (GTP-bound and total) and PAK1 (phosphorylated form and total) in NIH3T3 cells transfected with cIAP1
L47A encoding plasmid vector 24 h before serum starvation. Cells were stimulated for 10 min or for the indicated time with 100 ng/ml TNF. HSC70 was used as a loading control. (c) HEK293T cells were transfected with HA-cdc42 and FLAG-cIAP1 and treated or not for 10 min with 100 ng/ml TNF. Immunoprecipitation was performed using an anti-HA antibody and interactions were revealed by immunoblotting using anti-cIAP1, TRAF2 and HA antibodies. À / À MEFs were injected subcutaneously into nude mice. The tumour was analysed 10 days later (two independent experiments are shown, n ¼ 5 per group). The Mann-Whitney test was used for statistical analysis (*Po0.05). (e) HRas-V12-infected wt or cIAP1 À / À MEFs were injected into the tail veins of nude mice. Lung cancer foci were quantified 2 weeks later (two independent experiments are shown, n ¼ 4 per group). The Mann-Whitney test was used for statistical analysis (***P ¼ 0.0006). (f ) CSFElabelled PC3 cells, transfected with control or cIAP1-targeting siRNAs, were added on the HUVEC confluent monolayer. PC3 cell adhesion was quantified by flow cytometry (mean ± s.d. of two independent experiments) (left panel). The efficiency of siRNAs was checked by western blot analysis. (Upper panel). PC3 cell intercalation was evaluated by counting cells that display a non-round shape and a low phase-bright by timelapse microscopy. (4100 cells were analysed. The mean reflects±s.d. of at least three independent experiments) (right panel). Statistical analysis was performed using an ANOVA test (***Po0.001; **0.001oPo0.01). (g) CFSE-labelled wt or cIAP1 À / À MEFs, transduced or not with the HRas-V12 construct, were added on the HUVEC confluent monolayer. MEF adhesion (left panel) and intercalation (right panel) were evaluated as in (f ) (4100 cells were analyzed. The mean reflects ± s.d. of at least three independent experiments). Statistical analysis was performed using an ANOVA test (***Po0.001). Figure 9) . Accordingly, with the presence of filopodia-like structures on the cell surface, the cIAP1 À / À MEFs spontaneously adhered to the HUVEC monolayer more strongly compared with the wt counterpart (Figure 7g, left panel) . HRas-V12 expression stimulated the attachment of MEFs to the HUVEC monolayer (Figure 7g, left  panel) . Both the adhesion and the intercalation were decreased in HRas-V12-transformed cIAP1 À / À MEFs compared with HRas-V12/ wt MEFs (Figure 7g) . DISCUSSION cIAP1 is a key determinant of the cellular response to TNF. The protein is recruited to the TNFR1 through the adaptor TRAF2 and mediates the activation of the canonical NF-kB survival pathway while inhibiting the assembly of the secondary cytoplasmic caspase-activating platform, leading to cell death. 20 We demonstrate here that cIAP1 also regulates actin-cytoskeleton reorganization upon TNF stimulation through a cdc42-dependent, NF-kB-independent pathway. We propose a model (Figure 8 ) in which cIAP1 could regulate the cycle of cdc42 activation by stabilizing the interaction of cdc42 with its regulator RhoGDIa. The recruitment of TRAF2/cIAP1 to the TNF membrane receptor after TNF stimulation could release cdc42 and allow its activation, leading to the actin cytoskeleton reorganization.
In fibroblasts, TNF induces the rapid and transient formation of filopodia, 38 which requires the Rho GTPase cdc42. 5, 39, 40 The pathway connecting the TNFR1 to Rho GTPases remains poorly understood but appeared to be independent of NF-kB and MAPK activation. 5, 29, 38 Accordingly, we observed that TNF induced filopodia formation in the presence of an IkB super-repressor. TNFR engagement triggers the TRAF2-dependent recruitment of cIAP1, which induces an autoubiquitination and the ubiquitination of RIP1 necessary for NF-kB activation. 20 We demonstrate that TNF-induced filopodia formation requires cIAP1 and TRAF2, whereas RIP1 and the E3-ubiquitin ligase of cIAP1 are dispensable, suggesting that the TNFR-associated complex can generate independent signaling pathways leading to NF-kB activation or filopodia formation. cIAP1 can directly bind to cdc42, whereas TRAF2 can bind to cdc42 only in the presence of cIAP1. Both cIAP1 and TRAF2 co-precipitate with cdc42 in resting cells, and TNF treatment decreased this interaction. Our hypothesis is that the recruitment of cIAP1/TRAF2 to TNFR makes cdc42 activation easier, leading to actin cytoskeleton reorganization (Figure 8 ). Secondary molecular events are likely required for the full activation of cdc42, as the activation of Rho GTPases requires a GEF. Vav is a Rac1-GEF in TNFa signaling in fibroblasts, 29 and the GEF Ect2 has been involved in the TNF-like weak inducer of apoptosis (TWEAK)-induced cdc42 activation in glioblastoma; 41 however, their role in cdc42 activation has to be explored in this cell context. cIAP1 appears to fine-tune cdc42 activation. On one hand, cIAP1 deletion inhibits cdc42 activation in response to TNF and EGF stimulation and HRas-V12 expression; on the other hand, downregulation of cIAP1 decreases the expression of the whole cdc42 in a proteasome-dependent manner but increases the expression of the activated fraction of cdc42. The downregulation of cIAP1 also promotes the phosphorylation of PAK1, a cdc42 effector, and cIAP1 À / À MEFs spontaneously form filopodia-like structures. Interestingly, RhoGDIa depletion infers similar modifications, including a decreased cdc42 protein level that can be prevented by inhibiting the proteasome, and an increased ratio of active to total cdc42. 27 RhoGDIa is a Rho chaperone; that is, it maintains a pool of cytoplamic GTPases in a GDP-bound inactive state and protects them from proteasomal degradation. 27, 42 The expression of cIAP1 increases the cytosolic cdc42 expression in a RhoGDIadependent manner and enhances the fraction of the cdc42 bound to RhoGDIa. Overall, these data argue for a RhoGDIa-mediated regulation of cdc42 by cIAP1.
The regulation of RhoGTPases by IAPs is evolutionarily conserved; that is, it has been observed in Drosophila 43 and Zebrafish. 25 Identical to RhoGDIs, 42 cIAP1 (present work), XIAP 25 and DIAP1 43 can bind to both GDP-and GTP-bound GTPases. DIAP1 controls Rac activity independently of its E3-ubiquitine ligase domain, 43 whereas XIAP promotes the ubiquitination and degradation of the active GTP-bound form of Rac1. 25 We observed an interaction of cIAP1 with Rac1, RhoA and cdc42. In our study, cIAP1 failed to ubiquitinate cdc42 (Supplementary Figure 10) , Figure 8 . Model for the regulation of cdc42 by cIAP1/TRAF2. cIAP1 interacts with TRAF2 via the BIR1 (B1) domain and with cdc42 via the BIR2 (B2) domain. (1) In resting cells, cIAP1 binds cdc42. It stabilizes its interaction with its regulator RhoGDIa and then regulates cdc42 activation. ( 2) The recruitment of TRAF2/cIAP1 to the receptor after TNF stimulation releases cdc42 and makes its activation easier, leading to cytoskeleton reorganization and filopodia formation. (3) Depletion of cIAP1 induces a loss of control of cdc42 and increases the activation/ degradation cycle, leading to cytoskeleton modifications and a filopodia-like structure. suggesting that IAPs could differentially modulate various Rho GTPases. RhoA, Rac1 and cdc42 compete for the binding to and chaperoning by RhoGDIa, and the stabilization of the interaction of one Rho GTPase with RhoGDIa favours the degradation of the others. 27 cIAP1 becomes a part of this crosstalk regulatory mechanism by stabilizing cdc42-RhoGDIa interaction (present work) and catalysing the proteasomal degradation of Rac1. 25 Moreover, an inhibition of the SUMOylation of RhoGDIa by XIAP has been described 44 and a recent study identified RhoGDI2 as a potential IAP neddylation substrate. 45 As central regulators of Rho GTPase homeostasis, IAPs could regulate their sequential activation in many biological processes such as intracellular vesicular traffic, morphogenesis, tissue repair, cell shape, plasticity, polarization, adhesion and motility. 42 In drosophila, overexpression of DIAP1 compensates the invalidation of rac in the control of border cell migration during oogenesis. 43 In mammals, the depletion of cIAPs or XIAP alters the invasive properties of cancer cells, including their migration, 19, 25, 44, 46 their adhesion to the endothelium and their intercalation between endothelial cells, which can be related to the deregulation of Rho GTPase homeostasis. 25, 43, 44 Our results indicate a regulatory function for cIAP1 in cdc42-controlled filopodia formation, cell polarization and adhesion. 39, 47 The contribution of cdc42 to some oncogenic processes, 6 for example, HRas-V12-driven cell transformation 33, 35, 36 and metastatic invasion, 37 may account for the anti-tumour activity of small molecule inhibitors of IAPs, such as Smac mimetics.
MATERIALS AND METHODS

Cell culture and treatments
Mouse embryonic immortalized (SV40) fibroblasts (MEF) wt and cIAP1
Silke, Melbourne, Australia), mouse NIH3T3 fibroblasts and HEK293T cells were cultured in DMEM medium (Lonza, Verviers, Belgium) supplemented with 10% fetal bovine serum (FBS) (Lonza). Cells were serum starved for 16 h before stimulation with 100 ng/ml TNF or EGF (Shenandoah Biotechnology Inc, Warwick, PA, USA). MG132 (Millipore, Calbiochem, Billerica, MA, USA) was used at 40 mM for 4 hours. PC3 cells were cultivated in RPMI-1640 medium (Lonza) supplemented with 10% FBS (Lonza). Primary HUVECs (Lonza) were maintained in EBM2 medium (Lonza).
Plasmid constructs, siRNAs, cell transfection and viral transduction NIH3T3 fibroblasts were transfected using Lipofectamine 2000 (Life technologies, Invitrogen, Carlsbad, CA, USA), and MEFs and HEK293T were transfected using JET PEI (Polyplus transfection, Illkirch, France). Lipofectamine 2000 (Invitrogen) was used for the transfection of siRNA targeting mouse NIK (Thermo Fisher Scientific, Waltham, MA, USA), cIAP1, TRAF2, RIP1 or RhoGDIa (designed and provided by Qiagen, Venlo, The Netherlands). The DNA constructs used were pCR3-Flag-cIAP1, pCR3-flagcIAP1 L47A , pCI-cIAP1, pCI-cIAP1 H588A , pCI-cIAP1 . HRas-V12 expressing MEFs were generated by retroviral transduction. Phoenix-Eco cells (Invitrogen), which constitutively produced gag-pol and ecotropic envelope proteins, were transfected using Jet PEI (Polyplus transfection) with pMSCV-HRas-V12. MEFs were transduced overnight with the retroviral-containing supernatant supplemented with 1 mg/ml polybrene (Sigma-Aldrich, St-Louis, MO, USA). Populations of transduced cells were selected by puromycin exposure. The efficiency of infection was checked by western blot analysis.
Immunofluorescence analysis of filopodia and cell polarity Cells were grown and transfected on a chamber slide (Labtek, Thermo Fisher Scientific, Nunc), serum starved for 16 h and stimulated with TNF or EGF. Cells were then washed twice with pre-warmed PBS, fixed for 10 min in 4% paraformaldehyde/PBS, permeabilized using 0.1% triton X-100 (10 min) and saturated for 20 min in 2% bovine serum albumin. Actin cytoskeleton was labelled with AlexaFluor488-Phalloidin (Invitrogen) in PBS/BSA 0.5% for 30 min. Cells were mounted on glass slides using FluorSave (Millipore, Billerica, MA, USA) and examined using a fluorescence (Nikon Eclipse 80i, Nikon, Champigly, France) or a confocal (Leica TCS SP2; Leica, Bron, France) microscope. Filopodia were quantified by counting cells displaying more than five filopodia or by counting the number of filopodia/cell. More than 100 cells were analysed.
Cell polarity was assessed by an analysis of the Golgi apparatus orientation in a wound-scratch test. Briefly, after wounding, cell monolayers were fixed and subjected to nucleus and Golgi staining using Hoechst 33258 (Sigma-Aldrich) and AlexaFluor568-conjugated anti-GM130 (Becton, Dickinson and Company, Franklin Lakes, NJ, USA), respectively. The percentage of cells (4150) with their Golgi orientated towards the wound was evaluated.
Cellular extracts, cell fractionation, immunoprecipitation and western blot analysis Cells were lysed in RIPA (Tris-HCl 50 mM pH 7.5, NaCl 150 mM, NP-40 1%, DOC 0.5%, SDS 0.1%) or Phospho (Tris-HCl 50 mM pH 7.5, NaCl 100 mM, NP-40 2%, Glycerol 10%, MgCl 2 10 mM, NaF 10 mM, Sodium orthovanadate 1 mM, phosphatase inhibitor phosphatase 2 and 3) buffers complemented with EDTA-free protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO USA). Primary antibodies used for western blotting were goat anti-cIAP1 (R&D Systems, Minneapolis, MN, USA) and GST (Rockland Immunochemicals, Philadelphia, Pennsylvania, USA), rabbit anti-GFP (Becton, Dickinson and Company, Franklin Lakes, NJ, USA), RhoGDIa (Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA), PAK1, p-PAK1, Cofilin, p-Cofilin, GSK3a/b, P-GSK3a/b (Cell Signaling Technology Inc, Danvers, MA, USA) and TRAF2 (Millipore Corporation, Upstate, Billerica, Massachusetts, USA), and mouse anti-HA (Covance), Rac1 (Upstate), cdc42 (Becton, Dickinson and Company), RhoA (Cytoskeleton Inc, Denver, CO, USA), cIAP2, pan-cIAPs (R&D Systems, Cyclex), GM130 (Becton, Dickinson and Company) and HSC70 (Santa Cruz Biotechnology Inc). The western blot analysis was performed as previously described. 22 Cell fractionation experiments were performed using the Subcellular Protein Fractionation Kit for Cultured Cells (Thermo Fisher Scientific) according to the manufacturer's instructions.
For immunoprecipitations, cells were lysed in IP buffer (50 mM TrisHCl pH7.5, NaCl 100 mM, NP-40 2%, Glycerol 10%, MgCl 2 10 mM, NaF 10 mM, Sodium orthovanadate 1 mM protease inhibitor cocktail) and incubated for 4 h at 4 C in the presence of rabbit polyclonal anti-RhoGDIa or mouse anti-HA and then for 1 h in the presence of mixed A þ G agarose beads (Millipore). Beads were washed in IP buffer and denaturated in Laemmli buffer 2X before immunoblot analysis.
Rho GTPase activation assays
Cells were lysed in GTPase buffer (Tris-HCl 50 mM pH 7.5, NaCl 300 mM, NP-40 2, Glycerol 10%, 10 mM MgCl 2 , protease inhibitor cocktail). The active forms of RhoA, rac1 or cdc42 were selectively pulled down by the GST-Rhotekin-Rho binding domain or GST-PAK1-CRIB domain fused to glutathione-Sepharose beads (GE Healthcare, Amersham Biosciences, Fairfield, CT, USA). Beads were washed three times and eluted in Laemmli 2X, and precipitated GTP-RhoA or Rac or Cdc42 was detected by western blot analysis using an anti-RhoA or Rac1 or Cdc42 antibody.
GST pull-down assay GST fusion proteins were produced in Escherichia coli, immobilized on glutathione-Sepharose (Amersham Biosciences, Fairfield, CT, USA) and incubated with either tagged protein-expressing HEK293T cell lysates or recombinant cIAP1 or TRAF2 (SignalChem, Richmond, Canada). The pulldown proteins were revealed by western blot analysis. Recombinant cIAP1 protein was produced using a TNT-quick coupled transcription/translation system (Promega, Madison, WI, USA) according to the manufacturer's instructions. For the analysis of the interaction with the GDP-or GTPbound form of cdc42, GST-cdc42 or cdc42 from cell lysates was charged with GDP (1 mM) or GTPgS (0.1 mM) (Millipore) in 0.5 M EDTA for 15 min at 30 1C under agitation before the pull-down assay. The reaction was stopped by adding 60 mM MgCl 2 . cIAP1 regulates cdc42 A Marivin et al Surface Plasmon Resonance (Biacore) analysis Design and fabrication of homemade chips compatible with Surface Plasmon Resonance was routinely performed with the help of the MIMENTO technological platform, Besanc¸on, France. The cIAP1-BIRs chips fabricated in this study consisted in the covalent grafting of cIAP1 entities on a chemically activated self-assembled monolayer following the procedure of protein chip building recently published. 49 This procedure was performed in a 10 mM acetate buffer (pH4.5) and led to a surface coverage of approximately 8 fmol/mm 2 of cIAP1-BIRs per spot. Biacore experiments were performed with the Biacore 2000 apparatus at 25 1C with a flow rate between 2 and 30 ml/min. Purified cdc42 was charged with GDP (1 mM) or GTPgS (0.1 mM) (Millipore) in 0.5 M EDTA for 15 min at 30 1C under agitation and injected into the Biacore. Protein-protein interaction was monitored using Biacore 200 control software (GE-Healthcare, Little Chalfont, UK) and analysed using Biaevaluation 3.2 RCI software (GEHealthcare, Little Chalfont, UK).
Soft agar colony formation
Cells (50 000 cells/well) were cultured in 0.45% agarose in growth media and layered on top of 0.75% agarose growth media in a six-well dish. Colonies were counted under a light microscope 2-3 weeks post plating. For each experiment, cells were seeded in triplicate and three fields per well were quantified.
Mouse tumoural models
Exponentially growing HRas-V12 and control-transduced MEF cells (1 Â 10 6 /100 ml PBS) were s.c. injected into the flank of nude mice. Tumour growth was monitored by measuring with calipers in two perpendicular diameters, and tumour volumes were calculated using the formula v ¼ a 2 b/2 (aob). For the analysis of lung colonization, HRas-V12-transduced MEFs (1 Â 10 6 / 100 ml PBS) were injected into the tail veins of nude mice. The mice were killed 2 weeks later, and the number of tumour foci at the lung surface was counted. Lungs were fixed and sections were stained with haematoxylin and eosin and observed using AxioZOOM V16 (Carl Zeiss, Oberkoren, Germany). The experiments were performed twice n ¼ 4-5 per group.
Cell adhesion and intercalation
Cell adhesion and intercalation assay was performed as previously described. 37 Briefly, 130 000 CSFE-labelled PC3 cells or MEFs were added onto confluent HUVECs in 24-well plates and washed twice with PBS. Cells were trypsinized and adherent cells were quantified using a LSRII flow cytometer (Becton, Dickinson and Company, Franklin Lakes, NJ, USA). For the analysis of intercalation, 150 000 PC3 cells or MEFs were added onto confluent HUVECs in 6-well plates. Cells were monitored by time-lap microscopy in a humidified chamber at 37 C and 5% CO2 with an inverted microscope AxioVert 200 M (Carl Zeiss) equipped with a motorized stage with a 10x objective lens and using AxioVison software (Carl Zeiss). Cells were tracked manually using AxioVision software and cells were considered as intercalated when they were no more round, when they were no longer phase-bright and were clearly part of the HUVEC monolayer, as shown in Supplementary Figure 9 .
Stastitical analysis
Student's t test, ANOVA or the Mann-Whitney test was used for statistical analysis
